String of NIH departures continues as Ned Sharpless, head of the National Cancer Institute, steps down
String of NIH departures continues as Ned Sharpless, head of [...]
CRISPR patent dispute not over yet as Emmanuelle Charpentier, universities appeal
CRISPR patent dispute not over yet as Emmanuelle Charpentier, universities [...]
ACC: Ionis-AstraZeneca antisense drug reduces troublesome cholesterol in phase 2b
ACC: Ionis-AstraZeneca antisense drug reduces troublesome cholesterol in phase 2b [...]
Big Pharma-backed $1B AMR Action Fund picks 1st antimicrobial biotech investments
Big Pharma-backed $1B AMR Action Fund picks 1st antimicrobial biotech [...]
Legend Biotech CSO abruptly leaves Johnson & Johnson’s CAR-T partner he co-founded
Legend Biotech CSO abruptly leaves Johnson & Johnson’s CAR-T partner [...]
SAB vows to plow ahead with COVID-19 therapy after NIH drops out
SAB vows to plow ahead with COVID-19 therapy after NIH [...]
Leaping forward: Bayer VC arm commits $1.4B to double investment pace through 2024
Leaping forward: Bayer VC arm commits $1.4B to double investment [...]
Sage’s phase 2 Alzheimer’s drug shows signs of cognitive improvement—but there’s a catch
Sage’s phase 2 Alzheimer’s drug shows signs of cognitive improvement—but [...]
With 2023 launch in sight, Pharming shares pivotal data on ex-Novartis rare disease drug
With 2023 launch in sight, Pharming shares pivotal data on [...]
Finch clips wings of hepatitis B program, hitting pause on clinical plan to focus on C. diff and autism
Finch clips wings of hepatitis B program, hitting pause on [...]